Basel Medical Group Ltd (BMGL)
NASDAQ: BMGL · Real-Time Price · USD
6.14
-0.47 (-7.11%)
At close: Jul 13, 2026, 4:00 PM EDT
6.00
-0.14 (-2.28%)
After-hours: Jul 13, 2026, 7:00 PM EDT

Basel Medical Group Balance Sheet

Millions SGD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Equivalents
1.343.041.951.221.56
Cash & Short-Term Investments
1.343.041.951.221.56
Cash Growth
-81.96%56.04%60.26%-22.14%-
Accounts Receivable
10.759.492.011.582.28
Other Receivables
1.72-10.5611.8811.75
Total Trade Receivables
12.479.4912.5613.4614.03
Inventory
0.330.490.070.090.07
Other Current Assets
0.030.271.59--
Total Current Assets
14.1813.2916.1714.7715.67
Net Property, Plant & Equipment
5.95.340.060.581.18
Long-Term Investments
0----
Other Long-Term Assets
0.050.050.080.030
Total Assets
20.1218.6816.3115.3816.85
Accounts Payable
3.676.572.582.192.41
Accrued Expenses
--0.440.480.39
Current Portion of Long-Term Debt
2.942.122.713.794.2
Other Current Liabilities
0.91.471.440.020.19
Total Current Liabilities
7.5210.167.166.477.19
Long-Term Debt
6.042.961.583.425.95
Other Long-Term Liabilities
0.040.12---
Total Long-Term Liabilities
6.083.081.583.425.95
Total Liabilities
13.613.248.759.8913.14
Common Stock
34.2134.2124.4600
Additional Paid-in Capital
-24.21-24.46-24.46--
Accumulated Other Comprehensive Income
-0.04-0.46---
Retained Earnings
-3.69-3.857.565.493.71
Total Common Shareholders' Equity
6.285.437.565.493.71
Minority Interest
0.250---
Shareholders' Equity
6.525.447.565.493.71
Total Liabilities & Equity
20.1218.6816.3115.3816.85
Total Debt
8.985.084.297.2110.15
Net Cash (Debt)
-7.64-2.03-2.34-6-8.59
Net Cash Per Share
-0.41-1.30-1.73-4.43-6.34
Book Value
6.285.437.565.493.71
Book Value Per Share
0.333.475.584.052.74
Tangible Book Value
6.285.437.565.493.71
Tangible Book Value Per Share
0.333.475.584.052.74
SEC Filings: 10-K · 10-Q